Cargando…
Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
Although pneumatic dilation is an accepted method for the treatment of achalasia, this therapy has high recurrence and complication rates, and prolonged follow-up studies on the parameters associated with various outcomes are rare. In this prospective 10-year follow-up study, a satisfactory therapeu...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617067/ https://www.ncbi.nlm.nih.gov/pubmed/26181569 http://dx.doi.org/10.1097/MD.0000000000001193 |
_version_ | 1782396757492105216 |
---|---|
author | Cheng, Peng Shi, Hai Zhang, Yanjie Zhou, Huabang Dong, Jinhua Cai, Yiting Hu, Xing Dai, Qiang Yang, Wenyan |
author_facet | Cheng, Peng Shi, Hai Zhang, Yanjie Zhou, Huabang Dong, Jinhua Cai, Yiting Hu, Xing Dai, Qiang Yang, Wenyan |
author_sort | Cheng, Peng |
collection | PubMed |
description | Although pneumatic dilation is an accepted method for the treatment of achalasia, this therapy has high recurrence and complication rates, and prolonged follow-up studies on the parameters associated with various outcomes are rare. In this prospective 10-year follow-up study, a satisfactory therapeutic effect was achieved without serious complications. We report the therapeutic experience with pneumatic dilation, having aimed to evaluate the long-term clinical safety and efficacy of pneumatic dilation. In total, 35 consecutive patients with idiopathic achalasia who underwent pneumatic dilation were followed up at regular intervals in person or by a phone interview over a 10-year period. The mean duration of the follow-up was 43.03 ± 26.34 months (range 6–120 months). Remission was assessed by the dysphagia classification and symptom scores. Patients’ clinical symptom scores were calculated before and at 6 to 36 months, 37 to 60 months, and >60 months after therapy. The influence of the patients’ age, gender, and disease duration on the therapeutic effect was analyzed. The success rate of the operation was 97.2% (35/36), without massive hemorrhaging, perforation or other serious complications. Dysphagia after the therapy was significantly eased (P < 0.01). In total, 35 patients have been followed up for 6 to 36 months after therapy, 21 cases for 37 to 60 months, and 5 cases for >60 months, and the patients’ symptom scores separately decreased significantly compared with the pretherapy scores (P < 0.01). For these patients, the 6 to 36 months remission rate was 85.7% (30/35), the 37 to 60 months rate was 61.9% (13/21), and the >60 months rate was 40% (2/5). The dilation effect had no relationship to the patient's age, gender, and disease duration (P > 0.05). The patients in 30 cases (85.7%) were successfully treated with a single dilation, in 4 cases (11.4%) with 2 dilations, and in 1 case (2.9%) with 3 dilations. These results suggest that endoscopic pneumatic dilation is an achalasia therapy with a good response; it is a simple and safe procedure with long-term clinical effectiveness. It is a preferred method in the treatment of achalasia. |
format | Online Article Text |
id | pubmed-4617067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-46170672015-10-27 Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia Cheng, Peng Shi, Hai Zhang, Yanjie Zhou, Huabang Dong, Jinhua Cai, Yiting Hu, Xing Dai, Qiang Yang, Wenyan Medicine (Baltimore) 4500 Although pneumatic dilation is an accepted method for the treatment of achalasia, this therapy has high recurrence and complication rates, and prolonged follow-up studies on the parameters associated with various outcomes are rare. In this prospective 10-year follow-up study, a satisfactory therapeutic effect was achieved without serious complications. We report the therapeutic experience with pneumatic dilation, having aimed to evaluate the long-term clinical safety and efficacy of pneumatic dilation. In total, 35 consecutive patients with idiopathic achalasia who underwent pneumatic dilation were followed up at regular intervals in person or by a phone interview over a 10-year period. The mean duration of the follow-up was 43.03 ± 26.34 months (range 6–120 months). Remission was assessed by the dysphagia classification and symptom scores. Patients’ clinical symptom scores were calculated before and at 6 to 36 months, 37 to 60 months, and >60 months after therapy. The influence of the patients’ age, gender, and disease duration on the therapeutic effect was analyzed. The success rate of the operation was 97.2% (35/36), without massive hemorrhaging, perforation or other serious complications. Dysphagia after the therapy was significantly eased (P < 0.01). In total, 35 patients have been followed up for 6 to 36 months after therapy, 21 cases for 37 to 60 months, and 5 cases for >60 months, and the patients’ symptom scores separately decreased significantly compared with the pretherapy scores (P < 0.01). For these patients, the 6 to 36 months remission rate was 85.7% (30/35), the 37 to 60 months rate was 61.9% (13/21), and the >60 months rate was 40% (2/5). The dilation effect had no relationship to the patient's age, gender, and disease duration (P > 0.05). The patients in 30 cases (85.7%) were successfully treated with a single dilation, in 4 cases (11.4%) with 2 dilations, and in 1 case (2.9%) with 3 dilations. These results suggest that endoscopic pneumatic dilation is an achalasia therapy with a good response; it is a simple and safe procedure with long-term clinical effectiveness. It is a preferred method in the treatment of achalasia. Wolters Kluwer Health 2015-07-17 /pmc/articles/PMC4617067/ /pubmed/26181569 http://dx.doi.org/10.1097/MD.0000000000001193 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 4500 Cheng, Peng Shi, Hai Zhang, Yanjie Zhou, Huabang Dong, Jinhua Cai, Yiting Hu, Xing Dai, Qiang Yang, Wenyan Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia |
title | Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia |
title_full | Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia |
title_fullStr | Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia |
title_full_unstemmed | Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia |
title_short | Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia |
title_sort | clinical effect of endoscopic pneumatic dilation for achalasia |
topic | 4500 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617067/ https://www.ncbi.nlm.nih.gov/pubmed/26181569 http://dx.doi.org/10.1097/MD.0000000000001193 |
work_keys_str_mv | AT chengpeng clinicaleffectofendoscopicpneumaticdilationforachalasia AT shihai clinicaleffectofendoscopicpneumaticdilationforachalasia AT zhangyanjie clinicaleffectofendoscopicpneumaticdilationforachalasia AT zhouhuabang clinicaleffectofendoscopicpneumaticdilationforachalasia AT dongjinhua clinicaleffectofendoscopicpneumaticdilationforachalasia AT caiyiting clinicaleffectofendoscopicpneumaticdilationforachalasia AT huxing clinicaleffectofendoscopicpneumaticdilationforachalasia AT daiqiang clinicaleffectofendoscopicpneumaticdilationforachalasia AT yangwenyan clinicaleffectofendoscopicpneumaticdilationforachalasia |